Ophiocordyceps unilateralis
| Ophiocordyceps unilateralis | |
|---|---|
| Dead ants infected with Ophiocordyceps unilateralis | |
| Scientific classification | |
| Kingdom: | Fungi |
| Division: | Ascomycota |
| Class: | Sordariomycetes |
| Order: | Hypocreales |
| Family: | Ophiocordycipitaceae |
| Genus: | Ophiocordyceps |
| Species: | O. unilateralis
|
| Binomial name | |
| Ophiocordyceps unilateralis | |
| Synonyms | |
|
Torrubia unilateralis Tul. (1865) | |
Ophiocordyceps unilateralis, commonly known as zombie-ant fungus, is an insect-pathogenic fungus, discovered by the British naturalist Alfred Russel Wallace in 1859. Zombie ants, infected by the Ophiocordyceps unilateralis fungus, are predominantly found in tropical rainforests.
These fungi thrive in warm, humid environments, which are ideal for their growth and reproduction. However, they can also be found in warm-temperate forest systems. The fungus primarily targets ants from the tribe Camponotini, including carpenter ants (genus Camponotus).
O. unilateralis infects ants of the tribe Camponotini, with the full pathogenesis being characterized by alteration of the behavioral patterns of the infected ant. Infected hosts leave their canopy nests and foraging trails for the forest floor, an area with a temperature and humidity suitable for fungal growth; they then use their mandibles to attach themselves to a major vein on the underside of a leaf, where the host remains after its eventual death. The process, leading up to mortality, takes 4–10 days, and includes a reproductive stage where fruiting bodies grow from the ant's head, rupturing to release the fungus's spores. O. unilateralis is, in turn, also susceptible to fungal infection itself, an occurrence that can limit its impact on ant populations, which has otherwise been known to devastate ant colonies.
Related species, like Tolypocladium inflatum produce secondary metabolites that have been a source of valuable pharmaceuticals. Organisms like O. unilateralis have often evolved to produce specific metabolites for their antibacterial and/or host modulating activities. As a result, some of these metabolites may prove to be useful pharmaceuticals.